Global and Japan Medical Biomedical Materials 3.0 Market Insights, Forecast to 2026

SKU ID :QYR-15994772 | Published Date: 30-Jul-2020 | No. of pages: 144
1 Study Coverage 1.1 Medical Biomedical Materials 3.0 Product Introduction 1.2 Market Segments 1.3 Key Medical Biomedical Materials 3.0 Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Medical Biomedical Materials 3.0 Market Size Growth Rate by Type 1.4.2 PLA 1.4.3 PGA 1.4.4 PLGA 1.4.5 PLCG 1.4.6 Other 1.5 Market by Application 1.5.1 Global Medical Biomedical Materials 3.0 Market Size Growth Rate by Application 1.5.2 Suture 1.5.3 Fracture Fixation 1.5.4 Oral Implant 1.5.5 Drug Delivery Microsphere 1.5.6 Others 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Medical Biomedical Materials 3.0 Market Size, Estimates and Forecasts 2.1.1 Global Medical Biomedical Materials 3.0 Revenue 2015-2026 2.1.2 Global Medical Biomedical Materials 3.0 Sales 2015-2026 2.2 Global Medical Biomedical Materials 3.0, Market Size by Producing Regions: 2015 VS 2020 VS 2026 2.3 Medical Biomedical Materials 3.0 Historical Market Size by Region (2015-2020) 2.3.1 Global Medical Biomedical Materials 3.0 Retrospective Market Scenario in Sales by Region: 2015-2020 2.3.2 Global Medical Biomedical Materials 3.0 Retrospective Market Scenario in Revenue by Region: 2015-2020 2.4 Medical Biomedical Materials 3.0 Market Estimates and Projections by Region (2021-2026) 2.4.1 Global Medical Biomedical Materials 3.0 Sales Forecast by Region (2021-2026) 2.4.2 Global Medical Biomedical Materials 3.0 Revenue Forecast by Region (2021-2026) 3 Global Medical Biomedical Materials 3.0 Competitor Landscape by Players 3.1 Global Top Medical Biomedical Materials 3.0 Sales by Manufacturers 3.1.1 Global Medical Biomedical Materials 3.0 Sales by Manufacturers (2015-2020) 3.1.2 Global Medical Biomedical Materials 3.0 Sales Market Share by Manufacturers (2015-2020) 3.2 Global Medical Biomedical Materials 3.0 Manufacturers by Revenue 3.2.1 Global Medical Biomedical Materials 3.0 Revenue by Manufacturers (2015-2020) 3.2.2 Global Medical Biomedical Materials 3.0 Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Medical Biomedical Materials 3.0 Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Medical Biomedical Materials 3.0 Revenue in 2019 3.2.5 Global Medical Biomedical Materials 3.0 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Medical Biomedical Materials 3.0 Price by Manufacturers 3.4 Global Medical Biomedical Materials 3.0 Manufacturing Base Distribution, Product Types 3.4.1 Medical Biomedical Materials 3.0 Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Medical Biomedical Materials 3.0 Product Type 3.4.3 Date of International Manufacturers Enter into Medical Biomedical Materials 3.0 Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global Medical Biomedical Materials 3.0 Market Size by Type (2015-2020) 4.1.1 Global Medical Biomedical Materials 3.0 Sales by Type (2015-2020) 4.1.2 Global Medical Biomedical Materials 3.0 Revenue by Type (2015-2020) 4.1.3 Medical Biomedical Materials 3.0 Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Medical Biomedical Materials 3.0 Market Size Forecast by Type (2021-2026) 4.2.1 Global Medical Biomedical Materials 3.0 Sales Forecast by Type (2021-2026) 4.2.2 Global Medical Biomedical Materials 3.0 Revenue Forecast by Type (2021-2026) 4.2.3 Medical Biomedical Materials 3.0 Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Medical Biomedical Materials 3.0 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Market Size by Application (2015-2026) 5.1 Global Medical Biomedical Materials 3.0 Market Size by Application (2015-2020) 5.1.1 Global Medical Biomedical Materials 3.0 Sales by Application (2015-2020) 5.1.2 Global Medical Biomedical Materials 3.0 Revenue by Application (2015-2020) 5.1.3 Medical Biomedical Materials 3.0 Price by Application (2015-2020) 5.2 Medical Biomedical Materials 3.0 Market Size Forecast by Application (2021-2026) 5.2.1 Global Medical Biomedical Materials 3.0 Sales Forecast by Application (2021-2026) 5.2.2 Global Medical Biomedical Materials 3.0 Revenue Forecast by Application (2021-2026) 5.2.3 Global Medical Biomedical Materials 3.0 Price Forecast by Application (2021-2026) 6 Japan by Players, Type and Application 6.1 Japan Medical Biomedical Materials 3.0 Market Size YoY Growth 2015-2026 6.1.1 Japan Medical Biomedical Materials 3.0 Sales YoY Growth 2015-2026 6.1.2 Japan Medical Biomedical Materials 3.0 Revenue YoY Growth 2015-2026 6.1.3 Japan Medical Biomedical Materials 3.0 Market Share in Global Market 2015-2026 6.2 Japan Medical Biomedical Materials 3.0 Market Size by Players (International and Local Players) 6.2.1 Japan Top Medical Biomedical Materials 3.0 Players by Sales (2015-2020) 6.2.2 Japan Top Medical Biomedical Materials 3.0 Players by Revenue (2015-2020) 6.3 Japan Medical Biomedical Materials 3.0 Historic Market Review by Type (2015-2020) 6.3.1 Japan Medical Biomedical Materials 3.0 Sales Market Share by Type (2015-2020) 6.3.2 Japan Medical Biomedical Materials 3.0 Revenue Market Share by Type (2015-2020) 6.3.3 Japan Medical Biomedical Materials 3.0 Price by Type (2015-2020) 6.4 Japan Medical Biomedical Materials 3.0 Market Estimates and Forecasts by Type (2021-2026) 6.4.1 Japan Medical Biomedical Materials 3.0 Sales Forecast by Type (2021-2026) 6.4.2 Japan Medical Biomedical Materials 3.0 Revenue Forecast by Type (2021-2026) 6.4.3 Japan Medical Biomedical Materials 3.0 Price Forecast by Type (2021-2026) 6.5 Japan Medical Biomedical Materials 3.0 Historic Market Review by Application (2015-2020) 6.5.1 Japan Medical Biomedical Materials 3.0 Sales Market Share by Application (2015-2020) 6.5.2 Japan Medical Biomedical Materials 3.0 Revenue Market Share by Application (2015-2020) 6.5.3 Japan Medical Biomedical Materials 3.0 Price by Application (2015-2020) 6.6 Japan Medical Biomedical Materials 3.0 Market Estimates and Forecasts by Application (2021-2026) 6.6.1 Japan Medical Biomedical Materials 3.0 Sales Forecast by Application (2021-2026) 6.6.2 Japan Medical Biomedical Materials 3.0 Revenue Forecast by Application (2021-2026) 6.6.3 Japan Medical Biomedical Materials 3.0 Price Forecast by Application (2021-2026) 7 North America 7.1 North America Medical Biomedical Materials 3.0 Market Size YoY Growth 2015-2026 7.2 North America Medical Biomedical Materials 3.0 Market Facts & Figures by Country 7.2.1 North America Medical Biomedical Materials 3.0 Sales by Country (2015-2020) 7.2.2 North America Medical Biomedical Materials 3.0 Revenue by Country (2015-2020) 7.2.3 U.S. 7.2.4 Canada 8 Europe 8.1 Europe Medical Biomedical Materials 3.0 Market Size YoY Growth 2015-2026 8.2 Europe Medical Biomedical Materials 3.0 Market Facts & Figures by Country 8.2.1 Europe Medical Biomedical Materials 3.0 Sales by Country 8.2.2 Europe Medical Biomedical Materials 3.0 Revenue by Country 8.2.3 Germany 8.2.4 France 8.2.5 U.K. 8.2.6 Italy 8.2.7 Russia 9 Asia Pacific 9.1 Asia Pacific Medical Biomedical Materials 3.0 Market Size YoY Growth 2015-2026 9.2 Asia Pacific Medical Biomedical Materials 3.0 Market Facts & Figures by Country 9.2.1 Asia Pacific Medical Biomedical Materials 3.0 Sales by Region (2015-2020) 9.2.2 Asia Pacific Medical Biomedical Materials 3.0 Revenue by Region 9.2.3 China 9.2.4 Japan 9.2.5 South Korea 9.2.6 India 9.2.7 Australia 9.2.8 Taiwan 9.2.9 Indonesia 9.2.10 Thailand 9.2.11 Malaysia 9.2.12 Philippines 9.2.13 Vietnam 10 Latin America 10.1 Latin America Medical Biomedical Materials 3.0 Market Size YoY Growth 2015-2026 10.2 Latin America Medical Biomedical Materials 3.0 Market Facts & Figures by Country 10.2.1 Latin America Medical Biomedical Materials 3.0 Sales by Country 10.2.2 Latin America Medical Biomedical Materials 3.0 Revenue by Country 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Medical Biomedical Materials 3.0 Market Size YoY Growth 2015-2026 11.2 Middle East and Africa Medical Biomedical Materials 3.0 Market Facts & Figures by Country 11.2.1 Middle East and Africa Medical Biomedical Materials 3.0 Sales by Country 11.2.2 Middle East and Africa Medical Biomedical Materials 3.0 Revenue by Country 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E 12 Company Profiles 12.1 Merck 12.1.1 Merck Corporation Information 12.1.2 Merck Description and Business Overview 12.1.3 Merck Sales, Revenue and Gross Margin (2015-2020) 12.1.4 Merck Medical Biomedical Materials 3.0 Products Offered 12.1.5 Merck Recent Development 12.2 PCAS 12.2.1 PCAS Corporation Information 12.2.2 PCAS Description and Business Overview 12.2.3 PCAS Sales, Revenue and Gross Margin (2015-2020) 12.2.4 PCAS Medical Biomedical Materials 3.0 Products Offered 12.2.5 PCAS Recent Development 12.3 Fujifilm 12.3.1 Fujifilm Corporation Information 12.3.2 Fujifilm Description and Business Overview 12.3.3 Fujifilm Sales, Revenue and Gross Margin (2015-2020) 12.3.4 Fujifilm Medical Biomedical Materials 3.0 Products Offered 12.3.5 Fujifilm Recent Development 12.4 Evonik Health Care 12.4.1 Evonik Health Care Corporation Information 12.4.2 Evonik Health Care Description and Business Overview 12.4.3 Evonik Health Care Sales, Revenue and Gross Margin (2015-2020) 12.4.4 Evonik Health Care Medical Biomedical Materials 3.0 Products Offered 12.4.5 Evonik Health Care Recent Development 12.5 Nomisma Healthcare 12.5.1 Nomisma Healthcare Corporation Information 12.5.2 Nomisma Healthcare Description and Business Overview 12.5.3 Nomisma Healthcare Sales, Revenue and Gross Margin (2015-2020) 12.5.4 Nomisma Healthcare Medical Biomedical Materials 3.0 Products Offered 12.5.5 Nomisma Healthcare Recent Development 12.6 Corbion 12.6.1 Corbion Corporation Information 12.6.2 Corbion Description and Business Overview 12.6.3 Corbion Sales, Revenue and Gross Margin (2015-2020) 12.6.4 Corbion Medical Biomedical Materials 3.0 Products Offered 12.6.5 Corbion Recent Development 12.7 DURECT 12.7.1 DURECT Corporation Information 12.7.2 DURECT Description and Business Overview 12.7.3 DURECT Sales, Revenue and Gross Margin (2015-2020) 12.7.4 DURECT Medical Biomedical Materials 3.0 Products Offered 12.7.5 DURECT Recent Development 12.8 Mitsui Chemicals 12.8.1 Mitsui Chemicals Corporation Information 12.8.2 Mitsui Chemicals Description and Business Overview 12.8.3 Mitsui Chemicals Sales, Revenue and Gross Margin (2015-2020) 12.8.4 Mitsui Chemicals Medical Biomedical Materials 3.0 Products Offered 12.8.5 Mitsui Chemicals Recent Development 12.9 Phosphorex Inc. 12.9.1 Phosphorex Inc. Corporation Information 12.9.2 Phosphorex Inc. Description and Business Overview 12.9.3 Phosphorex Inc. Sales, Revenue and Gross Margin (2015-2020) 12.9.4 Phosphorex Inc. Medical Biomedical Materials 3.0 Products Offered 12.9.5 Phosphorex Inc. Recent Development 12.10 Lattice Medical 12.10.1 Lattice Medical Corporation Information 12.10.2 Lattice Medical Description and Business Overview 12.10.3 Lattice Medical Sales, Revenue and Gross Margin (2015-2020) 12.10.4 Lattice Medical Medical Biomedical Materials 3.0 Products Offered 12.10.5 Lattice Medical Recent Development 12.11 Merck 12.11.1 Merck Corporation Information 12.11.2 Merck Description and Business Overview 12.11.3 Merck Sales, Revenue and Gross Margin (2015-2020) 12.11.4 Merck Medical Biomedical Materials 3.0 Products Offered 12.11.5 Merck Recent Development 12.12 Shenzhen Polymtek Biomaterial Co., Ltd. 12.12.1 Shenzhen Polymtek Biomaterial Co., Ltd. Corporation Information 12.12.2 Shenzhen Polymtek Biomaterial Co., Ltd. Description and Business Overview 12.12.3 Shenzhen Polymtek Biomaterial Co., Ltd. Sales, Revenue and Gross Margin (2015-2020) 12.12.4 Shenzhen Polymtek Biomaterial Co., Ltd. Products Offered 12.12.5 Shenzhen Polymtek Biomaterial Co., Ltd. Recent Development 12.13 Changchun Foliaplast Bio-tech Co., Ltd 12.13.1 Changchun Foliaplast Bio-tech Co., Ltd Corporation Information 12.13.2 Changchun Foliaplast Bio-tech Co., Ltd Description and Business Overview 12.13.3 Changchun Foliaplast Bio-tech Co., Ltd Sales, Revenue and Gross Margin (2015-2020) 12.13.4 Changchun Foliaplast Bio-tech Co., Ltd Products Offered 12.13.5 Changchun Foliaplast Bio-tech Co., Ltd Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter’s Five Forces Analysis 13.5 Primary Interviews with Key Medical Biomedical Materials 3.0 Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Medical Biomedical Materials 3.0 Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer
List of Tables Table 1. Medical Biomedical Materials 3.0 Market Segments Table 2. Ranking of Global Top Medical Biomedical Materials 3.0 Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Medical Biomedical Materials 3.0 Market Size Growth Rate by Type 2020-2026 (Ton) & (US$ Million) Table 4. Major Manufacturers of PLA Table 5. Major Manufacturers of PGA Table 6. Major Manufacturers of PLGA Table 7. Major Manufacturers of PLCG Table 8. Major Manufacturers of Other Table 9. Global Medical Biomedical Materials 3.0 Market Size Growth Rate by Application 2020-2026 (Ton) Table 10. Global Medical Biomedical Materials 3.0 Market Size by Region (Ton) & (US$ Million): 2020 VS 2026 Table 11. Global Medical Biomedical Materials 3.0 Sales by Regions 2015-2020 (Ton) Table 12. Global Medical Biomedical Materials 3.0 Sales Market Share by Regions (2015-2020) Table 13. Global Medical Biomedical Materials 3.0 Revenue by Regions 2015-2020 (US$ Million) Table 14. Global Medical Biomedical Materials 3.0 Sales Forecast by Region (2021-2026) (Ton) Table 15. Global Medical Biomedical Materials 3.0 Sales by Manufacturers (2015-2020) (Ton) Table 16. Global Medical Biomedical Materials 3.0 Sales Share by Manufacturers (2015-2020) Table 17. Global Medical Biomedical Materials 3.0 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 18. Global Medical Biomedical Materials 3.0 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Medical Biomedical Materials 3.0 as of 2019) Table 19. Medical Biomedical Materials 3.0 Revenue by Manufacturers (2015-2020) (US$ Million) Table 20. Medical Biomedical Materials 3.0 Revenue Share by Manufacturers (2015-2020) Table 21. Key Manufacturers Medical Biomedical Materials 3.0 Price (2015-2020) (US$/Ton) Table 22. Medical Biomedical Materials 3.0 Manufacturers Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Medical Biomedical Materials 3.0 Product Type Table 24. Date of International Manufacturers Enter into Medical Biomedical Materials 3.0 Market Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans Table 26. Global Medical Biomedical Materials 3.0 Sales by Type (2015-2020) (Ton) Table 27. Global Medical Biomedical Materials 3.0 Sales Share by Type (2015-2020) Table 28. Global Medical Biomedical Materials 3.0 Revenue by Type (2015-2020) (US$ Million) Table 29. Global Medical Biomedical Materials 3.0 Revenue Share by Type (2015-2020) Table 30. Medical Biomedical Materials 3.0 Average Selling Price (ASP) by Type 2015-2020 (US$/Ton) Table 31. Global Medical Biomedical Materials 3.0 Sales Share by Type (2021-2026) Table 32. Global Medical Biomedical Materials 3.0 Sales by Application (2015-2020) (Ton) Table 33. Global Medical Biomedical Materials 3.0 Sales Share by Application (2015-2020) Table 34. Global Medical Biomedical Materials 3.0 Sales Share by Application (2021-2026) Table 35. Global Medical Biomedical Materials 3.0 Sales Market Share Forecast by Application (2021-2026) Table 36. Global Medical Biomedical Materials 3.0 Revenue by Application (2015-2020) (US$ Million) Table 37. Global Medical Biomedical Materials 3.0 Revenue Market Share Forecast by Application (2021-2026) Table 38. Japan Medical Biomedical Materials 3.0 Sales (Ton) of Key Companies (2015-2020) Table 39. Japan Medical Biomedical Materials 3.0 Sales Share by Company (2015-2020) Table 40. Japan Medical Biomedical Materials 3.0 Revenue (US$ Million) by Company (2015-2020) Table 41. Japan Medical Biomedical Materials 3.0 Sales (Ton) by Type (2015-2020) Table 42. Japan Medical Biomedical Materials 3.0 Sales Share by Type (2015-2020) Table 43. Japan Medical Biomedical Materials 3.0 Revenue (US$ Million) Market Share by Type (2015-2020) Table 44. Japan Medical Biomedical Materials 3.0 Price (Ton) by Type (2015-2020) Table 45. Japan Medical Biomedical Materials 3.0 Sales (Ton) by Type (2021-2026) Table 46. Japan Medical Biomedical Materials 3.0 Sales Share by Type (2021-2026) Table 47. Japan Medical Biomedical Materials 3.0 Revenue (US$ Million) Market Share by Type (2021-2026) Table 48. Japan Medical Biomedical Materials 3.0 Revenue Share by Type (2021-2026) Table 49. Japan Medical Biomedical Materials 3.0 Price (Ton) by Type (2021-2026) Table 50. Japan Medical Biomedical Materials 3.0 Sales (Ton) by Application (2015-2020) Table 51. Japan Medical Biomedical Materials 3.0 Sales Share by Application (2015-2020) Table 52. Japan Medical Biomedical Materials 3.0 Revenue (US$ Million) Market Share by Application (2015-2020) Table 53. Japan Medical Biomedical Materials 3.0 Sales (Ton) by Application (2021-2026) Table 54. Japan Medical Biomedical Materials 3.0 Sales Share by Application (2021-2026) Table 55. Japan Medical Biomedical Materials 3.0 Revenue (US$ Million) Market Share by Application (2021-2026) Table 56. Japan Medical Biomedical Materials 3.0 Revenue Share by Application (2021-2026) Table 57. North America Medical Biomedical Materials 3.0 Sales by Country (2015-2020) (Ton) Table 58. North America Medical Biomedical Materials 3.0 Sales Market Share by Country (2015-2020) Table 59. North America Medical Biomedical Materials 3.0 Revenue by Country (2015-2020) (US$ Million) Table 60. North America Medical Biomedical Materials 3.0 Revenue Market Share by Country (2015-2020) Table 61. Europe Medical Biomedical Materials 3.0 Sales by Country (2015-2020) (Ton) Table 62. Europe Medical Biomedical Materials 3.0 Sales Market Share by Country (2015-2020) Table 63. Europe Medical Biomedical Materials 3.0 Revenue by Country (2015-2020) (US$ Million) Table 64. Europe Medical Biomedical Materials 3.0 Revenue Market Share by Country (2015-2020) Table 65. Asia Pacific Medical Biomedical Materials 3.0 Sales by Region (2015-2020) (Ton) Table 66. Asia Pacific Medical Biomedical Materials 3.0 Sales Market Share by Region (2015-2020) Table 67. Asia Pacific Medical Biomedical Materials 3.0 Revenue by Region (2015-2020) (US$ Million) Table 68. Asia Pacific Medical Biomedical Materials 3.0 Revenue Market Share by Region (2015-2020) Table 69. Latin America Medical Biomedical Materials 3.0 Sales by Country (2015-2020) (Ton) Table 70. Latin America Medical Biomedical Materials 3.0 Sales Market Share by Country (2015-2020) Table 71. Latin Americaa Medical Biomedical Materials 3.0 Revenue by Country (2015-2020) (US$ Million) Table 72. Latin America Medical Biomedical Materials 3.0 Revenue Market Share by Country (2015-2020) Table 73. Middle East and Africa Medical Biomedical Materials 3.0 Sales by Country (2015-2020) (Ton) Table 74. Middle East and Africa Medical Biomedical Materials 3.0 Sales Market Share by Country (2015-2020) Table 75. Middle East and Africa Medical Biomedical Materials 3.0 Revenue by Country (2015-2020) (US$ Million) Table 76. Middle East and Africa Medical Biomedical Materials 3.0 Revenue Market Share by Country (2015-2020) Table 77. Merck Corporation Information Table 78. Merck Description and Business Overview Table 79. Merck Medical Biomedical Materials 3.0 Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020) Table 80. Merck Medical Biomedical Materials 3.0 Product Table 81. Merck Recent Development Table 82. PCAS Corporation Information Table 83. PCAS Description and Business Overview Table 84. PCAS Medical Biomedical Materials 3.0 Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020) Table 85. PCAS Product Table 86. PCAS Recent Development Table 87. Fujifilm Corporation Information Table 88. Fujifilm Description and Business Overview Table 89. Fujifilm Medical Biomedical Materials 3.0 Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020) Table 90. Fujifilm Product Table 91. Fujifilm Recent Development Table 92. Evonik Health Care Corporation Information Table 93. Evonik Health Care Description and Business Overview Table 94. Evonik Health Care Medical Biomedical Materials 3.0 Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020) Table 95. Evonik Health Care Product Table 96. Evonik Health Care Recent Development Table 97. Nomisma Healthcare Corporation Information Table 98. Nomisma Healthcare Description and Business Overview Table 99. Nomisma Healthcare Medical Biomedical Materials 3.0 Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020) Table 100. Nomisma Healthcare Product Table 101. Nomisma Healthcare Recent Development Table 102. Corbion Corporation Information Table 103. Corbion Description and Business Overview Table 104. Corbion Medical Biomedical Materials 3.0 Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020) Table 105. Corbion Product Table 106. Corbion Recent Development Table 107. DURECT Corporation Information Table 108. DURECT Description and Business Overview Table 109. DURECT Medical Biomedical Materials 3.0 Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020) Table 110. DURECT Product Table 111. DURECT Recent Development Table 112. Mitsui Chemicals Corporation Information Table 113. Mitsui Chemicals Description and Business Overview Table 114. Mitsui Chemicals Medical Biomedical Materials 3.0 Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020) Table 115. Mitsui Chemicals Product Table 116. Mitsui Chemicals Recent Development Table 117. Phosphorex Inc. Corporation Information Table 118. Phosphorex Inc. Description and Business Overview Table 119. Phosphorex Inc. Medical Biomedical Materials 3.0 Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020) Table 120. Phosphorex Inc. Product Table 121. Phosphorex Inc. Recent Development Table 122. Lattice Medical Corporation Information Table 123. Lattice Medical Description and Business Overview Table 124. Lattice Medical Medical Biomedical Materials 3.0 Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020) Table 125. Lattice Medical Product Table 126. Lattice Medical Recent Development Table 127. Jinan Daigang Biomaterial Corporation Information Table 128. Jinan Daigang Biomaterial Description and Business Overview Table 129. Jinan Daigang Biomaterial Medical Biomedical Materials 3.0 Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020) Table 130. Jinan Daigang Biomaterial Product Table 131. Jinan Daigang Biomaterial Recent Development Table 132. Shenzhen Polymtek Biomaterial Co., Ltd. Corporation Information Table 133. Shenzhen Polymtek Biomaterial Co., Ltd. Description and Business Overview Table 134. Shenzhen Polymtek Biomaterial Co., Ltd. Medical Biomedical Materials 3.0 Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020) Table 135. Shenzhen Polymtek Biomaterial Co., Ltd. Product Table 136. Shenzhen Polymtek Biomaterial Co., Ltd. Recent Development Table 137. Changchun Foliaplast Bio-tech Co., Ltd Corporation Information Table 138. Changchun Foliaplast Bio-tech Co., Ltd Description and Business Overview Table 139. Changchun Foliaplast Bio-tech Co., Ltd Medical Biomedical Materials 3.0 Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020) Table 140. Changchun Foliaplast Bio-tech Co., Ltd Product Table 141. Changchun Foliaplast Bio-tech Co., Ltd Recent Development Table 142. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 143. Key Challenges Table 144. Market Risks Table 145. Main Points Interviewed from Key Medical Biomedical Materials 3.0 Players Table 146. Medical Biomedical Materials 3.0 Customers List Table 147. Medical Biomedical Materials 3.0 Distributors List Table 148. Research Programs/Design for This Report Table 149. Key Data Information from Secondary Sources Table 150. Key Data Information from Primary Sources List of Figures Figure 1. Medical Biomedical Materials 3.0 Product Picture Figure 2. Global Medical Biomedical Materials 3.0 Sales Market Share by Type in 2020 & 2026 Figure 3. PLA Product Picture Figure 4. PGA Product Picture Figure 5. PLGA Product Picture Figure 6. PLCG Product Picture Figure 7. Other Product Picture Figure 8. Global Medical Biomedical Materials 3.0 Sales Market Share by Application in 2020 & 2026 Figure 9. Suture Figure 10. Fracture Fixation Figure 11. Oral Implant Figure 12. Drug Delivery Microsphere Figure 13. Others Figure 14. Medical Biomedical Materials 3.0 Report Years Considered Figure 15. Global Medical Biomedical Materials 3.0 Market Size 2015-2026 (US$ Million) Figure 16. Global Medical Biomedical Materials 3.0 Sales 2015-2026 (Ton) Figure 17. Global Medical Biomedical Materials 3.0 Market Size Market Share by Region: 2020 Versus 2026 Figure 18. Global Medical Biomedical Materials 3.0 Sales Market Share by Region (2015-2020) Figure 19. Global Medical Biomedical Materials 3.0 Sales Market Share by Region in 2019 Figure 20. Global Medical Biomedical Materials 3.0 Revenue Market Share by Region (2015-2020) Figure 21. Global Medical Biomedical Materials 3.0 Revenue Market Share by Region in 2019 Figure 22. Global Medical Biomedical Materials 3.0 Sales Share by Manufacturer in 2019 Figure 23. The Top 10 and 5 Players Market Share by Medical Biomedical Materials 3.0 Revenue in 2019 Figure 24. Medical Biomedical Materials 3.0 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 25. Global Medical Biomedical Materials 3.0 Sales Market Share by Type (2015-2020) Figure 26. Global Medical Biomedical Materials 3.0 Sales Market Share by Type in 2019 Figure 27. Global Medical Biomedical Materials 3.0 Revenue Market Share by Type (2015-2020) Figure 28. Global Medical Biomedical Materials 3.0 Revenue Market Share by Type in 2019 Figure 29. Global Medical Biomedical Materials 3.0 Market Share by Price Range (2015-2020) Figure 30. Global Medical Biomedical Materials 3.0 Sales Market Share by Application (2015-2020) Figure 31. Global Medical Biomedical Materials 3.0 Sales Market Share by Application in 2019 Figure 32. Global Medical Biomedical Materials 3.0 Revenue Market Share by Application (2015-2020) Figure 33. Global Medical Biomedical Materials 3.0 Revenue Market Share by Application in 2019 Figure 34. Japan Medical Biomedical Materials 3.0 Sales Growth Rate 2015-2026 (Ton) Figure 35. Japan Medical Biomedical Materials 3.0 Revenue Growth Rate 2015-2026 (US$ Million) Figure 36. Japan Medical Biomedical Materials 3.0 Market Share in Global Market 2015-2026 Figure 37. Japan 5 and 10 Largest Medical Biomedical Materials 3.0 Players Market Share by Revenue in Medical Biomedical Materials 3.0 in 2019 Figure 38. Japan Medical Biomedical Materials 3.0 Revenue Share by Type (2015-2020) Figure 39. Japan Medical Biomedical Materials 3.0 Revenue Growth Rate by Type in 2015 & 2019 Figure 40. Japan Medical Biomedical Materials 3.0 Revenue Share by Application (2015-2020) Figure 41. Japan Medical Biomedical Materials 3.0 Revenue Growth Rate by Application in 2015 & 2019 Figure 42. North America Medical Biomedical Materials 3.0 Sales Growth Rate 2015-2020 (Ton) Figure 43. North America Medical Biomedical Materials 3.0 Revenue Growth Rate 2015-2020 (US$ Million) Figure 44. North America Medical Biomedical Materials 3.0 Sales Market Share by Country in 2019 Figure 45. North America Medical Biomedical Materials 3.0 Revenue Market Share by Country in 2019 Figure 46. U.S. Medical Biomedical Materials 3.0 Sales Growth Rate (2015-2020) (Ton) Figure 47. U.S. Medical Biomedical Materials 3.0 Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. Canada Medical Biomedical Materials 3.0 Sales Growth Rate (2015-2020) (Ton) Figure 49. Canada Medical Biomedical Materials 3.0 Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. Europe Medical Biomedical Materials 3.0 Sales Growth Rate 2015-2020 (Ton) Figure 51. Europe Medical Biomedical Materials 3.0 Revenue Growth Rate 2015-2020 (US$ Million) Figure 52. Europe Medical Biomedical Materials 3.0 Sales Market Share by Country in 2019 Figure 53. Europe Medical Biomedical Materials 3.0 Revenue Market Share by Country in 2019 Figure 54. Germany Medical Biomedical Materials 3.0 Sales Growth Rate (2015-2020) (Ton) Figure 55. Germany Medical Biomedical Materials 3.0 Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. France Medical Biomedical Materials 3.0 Sales Growth Rate (2015-2020) (Ton) Figure 57. France Medical Biomedical Materials 3.0 Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. U.K. Medical Biomedical Materials 3.0 Sales Growth Rate (2015-2020) (Ton) Figure 59. U.K. Medical Biomedical Materials 3.0 Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Italy Medical Biomedical Materials 3.0 Sales Growth Rate (2015-2020) (Ton) Figure 61. Italy Medical Biomedical Materials 3.0 Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Russia Medical Biomedical Materials 3.0 Sales Growth Rate (2015-2020) (Ton) Figure 63. Russia Medical Biomedical Materials 3.0 Revenue Growth Rate (2015-2020) (US$ Million) Figure 64. Asia Pacific Medical Biomedical Materials 3.0 Sales Growth Rate 2015-2020 (Ton) Figure 65. Asia Pacific Medical Biomedical Materials 3.0 Revenue Growth Rate 2015-2020 (US$ Million) Figure 66. Asia Pacific Medical Biomedical Materials 3.0 Sales Market Share by Region in 2019 Figure 67. Asia Pacific Medical Biomedical Materials 3.0 Revenue Market Share by Region in 2019 Figure 68. China Medical Biomedical Materials 3.0 Sales Growth Rate (2015-2020) (Ton) Figure 69. China Medical Biomedical Materials 3.0 Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Japan Medical Biomedical Materials 3.0 Sales Growth Rate (2015-2020) (Ton) Figure 71. Japan Medical Biomedical Materials 3.0 Revenue Growth Rate (2015-2020) (US$ Million) Figure 72. South Korea Medical Biomedical Materials 3.0 Sales Growth Rate (2015-2020) (Ton) Figure 73. South Korea Medical Biomedical Materials 3.0 Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. India Medical Biomedical Materials 3.0 Sales Growth Rate (2015-2020) (Ton) Figure 75. India Medical Biomedical Materials 3.0 Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. Australia Medical Biomedical Materials 3.0 Sales Growth Rate (2015-2020) (Ton) Figure 77. Australia Medical Biomedical Materials 3.0 Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Taiwan Medical Biomedical Materials 3.0 Sales Growth Rate (2015-2020) (Ton) Figure 79. Taiwan Medical Biomedical Materials 3.0 Revenue Growth Rate (2015-2020) (US$ Million) Figure 80. Indonesia Medical Biomedical Materials 3.0 Sales Growth Rate (2015-2020) (Ton) Figure 81. Indonesia Medical Biomedical Materials 3.0 Revenue Growth Rate (2015-2020) (US$ Million) Figure 82. Thailand Medical Biomedical Materials 3.0 Sales Growth Rate (2015-2020) (Ton) Figure 83. Thailand Medical Biomedical Materials 3.0 Revenue Growth Rate (2015-2020) (US$ Million) Figure 84. Malaysia Medical Biomedical Materials 3.0 Sales Growth Rate (2015-2020) (Ton) Figure 85. Malaysia Medical Biomedical Materials 3.0 Revenue Growth Rate (2015-2020) (US$ Million) Figure 86. Philippines Medical Biomedical Materials 3.0 Sales Growth Rate (2015-2020) (Ton) Figure 87. Philippines Medical Biomedical Materials 3.0 Revenue Growth Rate (2015-2020) (US$ Million) Figure 88. Vietnam Medical Biomedical Materials 3.0 Sales Growth Rate (2015-2020) (Ton) Figure 89. Vietnam Medical Biomedical Materials 3.0 Revenue Growth Rate (2015-2020) (US$ Million) Figure 90. Latin America Medical Biomedical Materials 3.0 Sales Growth Rate 2015-2020 (Ton) Figure 91. Latin America Medical Biomedical Materials 3.0 Revenue Growth Rate 2015-2020 (US$ Million) Figure 92. Latin America Medical Biomedical Materials 3.0 Sales Market Share by Country in 2019 Figure 93. Latin America Medical Biomedical Materials 3.0 Revenue Market Share by Country in 2019 Figure 94. Mexico Medical Biomedical Materials 3.0 Sales Growth Rate (2015-2020) (Ton) Figure 95. Mexico Medical Biomedical Materials 3.0 Revenue Growth Rate (2015-2020) (US$ Million) Figure 96. Brazil Medical Biomedical Materials 3.0 Sales Growth Rate (2015-2020) (Ton) Figure 97. Brazil Medical Biomedical Materials 3.0 Revenue Growth Rate (2015-2020) (US$ Million) Figure 98. Argentina Medical Biomedical Materials 3.0 Sales Growth Rate (2015-2020) (Ton) Figure 99. Argentina Medical Biomedical Materials 3.0 Revenue Growth Rate (2015-2020) (US$ Million) Figure 100. Middle East and Africa Medical Biomedical Materials 3.0 Sales Growth Rate 2015-2020 (Ton) Figure 101. Middle East and Africa Medical Biomedical Materials 3.0 Revenue Growth Rate 2015-2020 (US$ Million) Figure 102. Middle East and Africa Medical Biomedical Materials 3.0 Sales Market Share by Country in 2019 Figure 103. Middle East and Africa Medical Biomedical Materials 3.0 Revenue Market Share by Country in 2019 Figure 104. Turkey Medical Biomedical Materials 3.0 Sales Growth Rate (2015-2020) (Ton) Figure 105. Turkey Medical Biomedical Materials 3.0 Revenue Growth Rate (2015-2020) (US$ Million) Figure 106. Saudi Arabia Medical Biomedical Materials 3.0 Sales Growth Rate (2015-2020) (Ton) Figure 107. Saudi Arabia Medical Biomedical Materials 3.0 Revenue Growth Rate (2015-2020) (US$ Million) Figure 108. U.A.E Medical Biomedical Materials 3.0 Sales Growth Rate (2015-2020) (Ton) Figure 109. U.A.E Medical Biomedical Materials 3.0 Revenue Growth Rate (2015-2020) (US$ Million) Figure 110. Porter's Five Forces Analysis Figure 111. Medical Biomedical Materials 3.0 Value Chain Figure 112. Channels of Distribution Figure 113. Distributors Profiles Figure 114. Bottom-up and Top-down Approaches for This Report Figure 115. Data Triangulation Figure 116. Key Executives Interviewed
Merck PCAS Fujifilm Evonik Health Care Nomisma Healthcare Corbion DURECT Mitsui Chemicals Phosphorex Inc. Lattice Medical Jinan Daigang Biomaterial Shenzhen Polymtek Biomaterial Co., Ltd. Changchun Foliaplast Bio-tech Co., Ltd
  • PRICE
  • $3900
    $7800
    $5850
    Buy Now

Our Clients